688068 logo

Beijing Hotgen Biotech Co., Ltd. Stock Price

SHSE:688068 Community·CN¥10.9b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

688068 Share Price Performance

CN¥0
-111.00 (-100.00%)
CN¥0
-111.00 (-100.00%)
Price CN¥0

688068 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Mediocre balance sheet with very low risk.

2 Risks
0 Rewards

Beijing Hotgen Biotech Co., Ltd. Key Details

CN¥407.7m

Revenue

CN¥0

Cost of Revenue

CN¥407.7m

Gross Profit

CN¥618.2m

Other Expenses

-CN¥210.5m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
Apr 25, 2026
-2.37
100.00%
-51.64%
1.7%
View Full Analysis

About 688068

Founded
2005
Employees
850
CEO
Changqing Lin
WebsiteView website
www.hotgen.com.cn

Beijing Hotgen Biotech Co., Ltd. engages in the research, development, manufacture, and sale of medical and public safety inspection products of in-vitro diagnostic products in the field of biomedicine. It offers public safety solutions such as drug tasting, customs disease control, bioterrorism and food safety solutions. The company also provides clinical diagnostics and product solutions, including upconversion light, chemiluminescence, sugar capture, microfluidics, and genetic testing for testing of intestinal microorganisms, gastrointestinal foodborne infections, insect-borne diseases, respiratory pathogens, infectious diseases, Ebola virus antigen, biological warfare agents, microorganisms, and mycotoxins. Beijing Hotgen Biotech Co., Ltd. was founded in 2005 and is based in Beijing, China.

Recent 688068 News & Updates

Recent updates

No updates